Loading…
Valiant Organics (VALIANTORG)₹341.95−4.18%Specialty Chemicals
In the Jun 2026 quarter (consolidated), Valiant Organics reported sales of ₹232 Cr, up 13.8% from Jun 2025, and net profit of ₹28.89 Cr, up 262.5% year on year. For the year to Mar 2026, sales were ₹738 Cr and net profit ₹32.87 Cr.
Company filings, consolidated accounts; latest reported quarter Jun 2026
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 203 | 141 | 177 | 168 | 160 | 187 | 204 | 204 | 157 | 159 | 218 | 232 |
| Expenses | 188 | 139 | 179 | 152 | 159 | 172 | 183 | 180 | 136 | 146 | 192 | 190 |
| Operating Profit | 14.97 | 2.99 | −1.99 | 15.95 | 0.99 | 14.95 | 20.95 | 24.94 | 20.94 | 12.96 | 25.95 | 41.90 |
| OPM % | 7.9% | 1.8% | −1.2% | 8.9% | 0.5% | 8.0% | 10.0% | 11.9% | 13.0% | 8.0% | 11.9% | 17.9% |
| Other Income | 3.99 | 0.00 | −6.99 | 0.00 | 2.99 | 5.99 | 0.99 | 1.99 | 0.00 | 6.99 | 4.99 | 10.98 |
| Interest | 3.99 | 3.99 | 6.99 | 4.99 | 7.99 | 5.99 | 4.99 | 5.99 | 3.99 | 4.99 | 2.99 | 4.99 |
| Depreciation | 8.98 | 8.98 | 8.98 | 8.98 | 8.98 | 8.98 | 8.97 | 8.98 | 9.97 | 9.98 | 9.98 | 9.97 |
| Profit before tax | 6.01 | −10.01 | −24.99 | 1.99 | −13.99 | 5.99 | 7.01 | 10.99 | 6.99 | 6.01 | 17.99 | 36.99 |
| Tax % | 26.0% | −20.0% | −20.0% | 128.0% | −9.1% | 14.0% | 43.0% | 26.0% | 24.0% | 38.0% | 10.0% | 20.0% |
| Exceptional items | 0.00 | 0.00 | −8.99 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.99 | 0.00 | 0.00 |
| Net Profit | 4.98 | −7.97 | −19.94 | −0.99 | −11.96 | 4.98 | 3.99 | 7.97 | 5.98 | 3.99 | 15.94 | 28.89 |
| EPS (Rs) | 1.59 | −2.87 | −7.34 | −0.23 | −4.64 | 1.99 | 1.51 | 2.94 | 2.03 | 1.31 | 5.62 | 10.40 |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|
| Sales | 691 | 674 | 753 | 1,150 | 1,050 | 722 | 717 | 738 | 765 |
| Expenses | 512 | 495 | 550 | 950 | 890 | 687 | 667 | 654 | 664 |
| Operating Profit | 181 | 181 | 204 | 204 | 164 | 36.91 | 52.87 | 86.85 | 102 |
| OPM % | 25.9% | 26.9% | 26.9% | 17.9% | 16.0% | 5.0% | 7.0% | 11.9% | 13.3% |
| Other Income | 7.99 | 5.99 | 5.99 | 6.99 | 12.98 | 5.99 | 7.99 | 12.98 | 22.96 |
| Interest | 3.99 | 2.99 | 4.99 | 5.99 | 10.99 | 15.99 | 23.98 | 17.99 | 16.96 |
| Depreciation | 13.96 | 15.95 | 20.97 | 29.91 | 28.93 | 34.94 | 35.89 | 39.91 | 39.90 |
| Profit before tax | 171 | 168 | 185 | 176 | 137 | −8.99 | 2.01 | 41.98 | 67.98 |
| Tax % | 29.0% | 25.0% | 29.0% | 27.0% | 25.0% | −3.0% | 260.0% | 21.0% | — |
| Exceptional items | 1.99 | 0.00 | 0.00 | 0.00 | 3.99 | −1.99 | 0.00 | 3.99 | 3.99 |
| Net Profit | 121 | 125 | 130 | 128 | 103 | −7.98 | −2.99 | 32.87 | 54.80 |
| EPS (Rs) | 104.03 | 51.17 | 42.35 | 41.88 | 32.55 | −3.05 | −1.35 | 11.89 | 19.36 |
| Dividend payout % | 6.0% | 11.0% | 12.0% | 8.0% | 3.0% | 0.0% | 0.0% | 0.0% | — |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Equity Capital | 6.00 | 12.00 | 27.00 | 27.03 | 27.02 | 28.02 | 28.01 | 28.02 |
| Reserves | 254 | 374 | 474 | 585 | 661 | 701 | 697 | 730 |
| Borrowings | 76.87 | 140 | 209 | 364 | 274 | 257 | 249 | 256 |
| Other Liabilities | 113 | 144 | 166 | 217 | 277 | 263 | 210 | 217 |
| Total Liabilities | 448 | 669 | 875 | 1,192 | 1,239 | 1,248 | 1,183 | 1,231 |
| Fixed Assets | 150 | 276 | 510 | 543 | 670 | 643 | 657 | 694 |
| CWIP | 66.18 | 129 | 46.12 | 112 | 71.15 | 86.15 | 66.19 | 21.03 |
| Investments | 12.02 | 23.02 | 6.01 | 8.01 | 41.06 | 99.08 | 94.13 | 151 |
| Other Assets | 221 | 241 | 314 | 529 | 457 | 420 | 367 | 364 |
| Inventories | 47.97 | 44.97 | 72.03 | 114 | 126 | 114 | 88.96 | 91.99 |
| Trade receivables | 141 | 133 | 157 | 321 | 254 | 209 | 177 | 243 |
| Cash & equivalents | 3.99 | 12.96 | 30.92 | 44.89 | 7.98 | 3.99 | 7.98 | 1.99 |
| Total Assets | 448 | 669 | 875 | 1,192 | 1,239 | 1,248 | 1,183 | 1,231 |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | 75.84 | 161 | 113 | −30.89 | 237 | 83.79 | 55.87 | 91.69 |
| Cash from investing activity | −86.05 | −184 | −156 | −124 | −143 | −65.09 | −21.01 | −86.08 |
| Cash from financing activity | 0.99 | 26.96 | 48.99 | 167 | −112 | −22.97 | −31.98 | −10.99 |
| Net cash flow | −9.02 | 5.01 | 5.01 | 12.01 | −17.02 | −4.01 | 4.01 | −5.01 |
| Capex | 89.07 | 205 | 171 | 123 | 152 | 73.99 | 30.99 | 34.03 |
| Free cash flow | −12.97 | −43.91 | −57.82 | −153 | 108 | 18.95 | 26.91 | 58.89 |
| CFO / OP % | 68.1% | 112.0% | 78.1% | 6.0% | 162.1% | 238.1% | 106.1% | 103.1% |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Debtor days | 75 | 72 | 76 | 102 | 88 | 106 | 90 | 120 |
| Inventory days | 44 | 42 | 63 | 54 | 68 | 88 | 71 | 76 |
| Days payable | 69 | 82 | 93 | 63 | 89 | 159 | 119 | 102 |
| Cash conversion cycle | 49 | 31 | 44 | 92 | 66 | 33 | 41 | 94 |
| Working capital days | 46 | 20 | −1 | 21 | 11 | −3 | −10 | 0 |
| ROCE % | — | 39.0% | 29.9% | 20.9% | 14.0% | 1.0% | 3.0% | 5.0% |
For the Jun 2026 quarter, Valiant Organics reported sales of ₹232 Cr, up 13.8% year on year and net profit of ₹28.89 Cr, up 262.5% year on year. The operating margin was 17.9%.
Valiant Organics' sales for the year to Mar 2026 were ₹738 Cr; over the last twelve months they were ₹765 Cr.
Net profit for the year to Mar 2026 was ₹32.87 Cr, and ₹54.80 Cr over the last twelve months. Earnings per share over the same trailing period were ₹19.36.
Valiant Organics reported borrowings of ₹256 Cr at Mar 2026, against cash and equivalents of ₹1.99 Cr.
Cash from operations was ₹91.69 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹58.89 Cr.